CHRONIC DISEASES DISPROPORTIONATELY IMPACT THE MOST UNDERSERVED PATIENT GROUPS -SINCE 2012, WE CONVENED OVER 250 C- SUITE AND SENIOR EXECUTIVES FROM THE PROVIDER, PHARMA, PAYER, PATIENT AND OTHER HEALTHCARE SECTORS TO SHARE NEW IDEAS AROUND REDUCES BARRIERS TO CARE AND ADDRESSING SOCIAL DETERMINANTS OF HEALTH. AFRICAN AMERICANS REPRESENT 12 OF THE U.S. POPULATION BUT ONLY 5 OF CLINICAL TRIAL PARTICIPANTS CHI ORGANIZES AN EDUCATIONAL SYMPOSIUM FOCUSING ON DIVERSITY AND CLINICAL TRIALS SINCE 2011, AND WE BROUGHT TOGETHER OVER 700 CLINICAL TRIAL AND DIVERSITY EXPERTS TO SHARE IDEAS AND LEARN. 26 OF AMERICANS REPORTED BARRIERS THAT RESTRICT THEIR ACCESS TO CARE IN 2019, CHI CONVENED OVER 400 LEADING HEALTHCARE PROFESSIONALS, CLINICIANS, TECHNOLOGIST AND PATIENT GROUPS AT OUR SYMPOSIUM FOCUSING ON HEALTHY EQUITY AND DISPARITIES. ELIMINATING HEALTH DISPARITIES THAT AFFECT MINORITIES COULD SAVE THE U.S. ECONOMY NEARLY 230 BILLION WE COMPILED EXTENSIVE RESEARCH SURROUNDING HOW TO BETTER SERVE MINORITY PATIENTS VIA MORE CULTURALLY COMPETENT CARE, DATA ANALYTICS, AND INCREASED PATIENT ENGAGEMENT.
